News >

Chemoimmunotherapy Emerges as Frontline Standard in Squamous NSCLC

Brandon Scalea
Published: Thursday, Apr 25, 2019

Eric S. Nadler, MD

Eric S. Nadler, MD

Chemoimmunotherapy has emerged as the frontline standard of care in patients with squamous non–small cell lung cancer (NSCLC), but work still needs to be done by way of determining effective biomarkers and identifying other effective combinations, said Eric S. Nadler, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and MyelomaMay 30, 20192.0
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Publication Bottom Border
Border Publication